PPCB Stock Analysis: Buy, Sell, or Hold?
PPCB - Propanc Biopharma, Inc. Common Stock
$0.09
0.00 (-4.73%)
▼
5d:
-14.23%
30d:
-11.75%
90d:
-53.32%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 21, 2026
10d
Get Alerted When PPCB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PPCB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PPCB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PPCB is currently trading at $0.09, which is considered oversold relative to its 30-day fair value range of $0.10 to $0.12.
Technical Outlook: Technically, PPCB is in a strong downtrend. Immediate support is located at $0.09, while resistance sits at $0.11. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: PPCB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.52 (+1615.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PPCB is in a strong downtrend. Immediate support is located at $0.09, while resistance sits at $0.11. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: PPCB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $1.52 (+1615.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.10 -
$0.12
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 1615.6% below Wall St target ($1.52)
- CAUTION: 5-day price weakness (-14.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.10 -
$0.12
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.09
Resistance Level
$0.11
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Wall Street Target
$1.52
(+1615.6%)
Share & Embed Analysis
Last updated: May 10, 2026 9:16 AM ET
Data refreshes hourly during market hours. Next update: 10:16 AM
Data refreshes hourly during market hours. Next update: 10:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PPCB showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 58 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 58 HOLD |